Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2026)

Maravai Lifesciences Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 139.06% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at -$55.7 million (down 160.29% YoY), while the FY2025 annual figure was -$70.7 million, down 218.67% from the prior year.
• Free Cash Flow was $4.2 million for Q1 2026 at Maravai Lifesciences Holdings, up from -$35.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $162.6 million in Q2 2022 to a low of -$35.0 million in Q4 2025.
• Historically, Free Cash Flow has averaged $28.9 million across 5 years, with a median of $4.2 million in 2026.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow soared 355.95% in 2022, then sank 415.6% in 2025.
• A 5-year view of Free Cash Flow shows it stood at $84.0 million in 2022, then plunged by 110.72% to -$9.0 million in 2023, then slumped by 127.41% to -$20.5 million in 2024, then sank by 70.84% to -$35.0 million in 2025, then surged by 112.08% to $4.2 million in 2026.
• The last three Free Cash Flow figures came in at $4.2 million (Q1 2026), -$35.0 million (Q4 2025), and -$14.3 million (Q3 2025), per Business Quant data.